LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.99 | 84.90 | 6395 | 8212 | 0.7787 | 0.9256 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.99 | 84.90 | 503 | 8212 | 0.0612 | 0.3096 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.99 | 84.90 | 8434 | 8212 | 1.0270 | 1.0081 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.70 | 84.90 | 412 | 8484 | 0.0486 | 0.2684 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.70 | 84.90 | 6625 | 8484 | 0.7809 | 0.9269 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.70 | 84.90 | 543 | 8484 | 0.0640 | 0.3223 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.70 | 84.90 | 8731 | 8484 | 1.0291 | 1.0086 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.41 | 84.90 | 445 | 8766 | 0.0508 | 0.2810 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.41 | 84.90 | 6878 | 8766 | 0.7846 | 0.9288 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.41 | 84.90 | 572 | 8766 | 0.0652 | 0.3300 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.41 | 84.90 | 8936 | 8766 | 1.0194 | 1.0057 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.11 | 84.90 | 429 | 8988 | 0.0477 | 0.2723 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.11 | 84.90 | 7090 | 8988 | 0.7888 | 0.9307 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.11 | 84.90 | 645 | 8988 | 0.0718 | 0.3519 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 69.11 | 84.90 | 9250 | 8988 | 1.0291 | 1.0086 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.81 | 84.90 | 388 | 9132 | 0.0425 | 0.2525 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.81 | 84.90 | 7274 | 9132 | 0.7965 | 0.9337 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.81 | 84.90 | 637 | 9132 | 0.0698 | 0.3480 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.81 | 84.90 | 9520 | 9132 | 1.0425 | 1.0124 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.52 | 84.90 | 466 | 9214 | 0.0506 | 0.2864 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.52 | 84.90 | 7473 | 9214 | 0.8110 | 0.9390 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.52 | 84.90 | 702 | 9214 | 0.0762 | 0.3667 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.52 | 84.90 | 9737 | 9214 | 1.0567 | 1.0164 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.22 | 84.90 | 392 | 9343 | 0.0420 | 0.2530 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.22 | 84.90 | 7531 | 9343 | 0.8060 | 0.9374 | MN20160318_Q02 | E19 |